Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers.

NCT07509268 is registered in ClinicalTrials.gov with Universidad Autonoma de Nuevo Leon as lead sponsor.

NCT NCT07509268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07509268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers.
Lead sponsor
Universidad Autonoma de Nuevo Leon
Phase
Phase 2
Overall status
Completed
Start date
September 9, 2022
Completion date
October 30, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer